
Mandar A. Aras MD PhD
Heart Failure & Transplantation
Associate Professor
Join to View Full Profile
505 Parnassus AveSan Francisco, CA 94143
Dr. Aras is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Mandar Aras, MD, PhD is a Cardiologist based in San Francisco, CA. He has subspecialized in Heart Failure & Transplantation, and focuses on infiltrative, inflammatory, and genetic cardiomyopathy.
Education & Training
- University of California (San Francisco) School of MedicineFellowship, Heart Failure, Heart Transplant, and Pulmonary Hypertension, 2017 - 2018
- University of California (San Francisco)Fellowship, Cardiovascular Disease, 2014 - 2017
- Duke University HospitalResidency, Internal Medicine, 2011 - 2014
- University of Pittsburgh School of MedicineClass of 2011, MD, PhD
Certifications & Licensure
- CA State Medical License 2014 - 2025
- NC State Medical License 2011 - 2014
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
Publications & Presentations
PubMed
- Acoramidis for Transthyretin Amyloid Cardiomyopathy: Open-Label Extension Study Long-Term Follow-Up.Ahmad Masri, Mandar Aras, Martha Grogan, Daniel Jacoby, Mathew S Maurer
Journal of Cardiac Failure. 2025-04-09 - 1 citationsImmune Checkpoint Inhibitor Myocarditis and Left Ventricular Systolic Dysfunction.Yen-Chou Chen, Charles Dolladille, Anjali Rao, Nicolas L Palaskas, Anita Deswal
JACC. Cardiooncology. 2025-04-01 - Longitudinal Evaluation of Immune Checkpoint Inhibitor-Induced Fatigue Syndrome by Rest, Stress, and Speckle-Tracking Strain Echocardiography.Katy K Tsai, Andrew Y Chang, Christiane M Abouzeid, Mandar A Aras, Qizhi Fang
Echocardiography. 2025-04-01
Press Mentions
- Cardiac Echo Tracks Checkpoint Inhibitor DamageFebruary 3rd, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: